Pfizer chooses Exco InTouch eDiary technologies
Exco’s eDiary will allow patients to participate in the trial irrespective of their location, age or proximity to the site. The study, which will focus on new research
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
BAC’s CaptureSelect affinity purification and separation products are provided for the discovery, preclinical and clinical manufacturing of therapeutic proteins, including antibodies and antibody fragments. The collaboration creates a